Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OYONO is a line of over-the-counter dietary supplements developed by Melisana Healthcare (a subsidiary of Klosterfrau Healthcare Group) designed to support sleep and relaxation. The flagship product, OYONO Nacht (OYONO Night), is formulated as an innovative three-phase tablet that provides a staggered release of its active ingredients over an eight-hour period. It contains a combination of melatonin, vitamin B6, and various plant extracts, including valerian root, lemon balm, passionflower, and hawthorn. The immediate phase releases melatonin, valerian, and vitamin B6 to facilitate falling asleep; the depot phase slowly releases melatonin and passionflower; and the chrono phase continuously releases hawthorn and lemon balm to support uninterrupted sleep. Other formulations in the product line include OYONO Nacht Intens (featuring ashwagandha and lavender) and OYONO Relax for daytime stress relief.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on OYONO.